Oncology Institute Total Liabilities 2020-2025 | TOI
Oncology Institute total liabilities from 2020 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Oncology Institute Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $169 |
| 2023 | $152 |
| 2022 | $138 |
| 2021 | $99 |
| 2020 | $38 |
| 2019 | $0 |
| Oncology Institute Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-06-30 | $169 |
| 2025-03-31 | $159 |
| 2024-12-31 | $169 |
| 2024-09-30 | $164 |
| 2024-06-30 | $150 |
| 2024-03-31 | $163 |
| 2023-12-31 | $152 |
| 2023-09-30 | $147 |
| 2023-06-30 | $145 |
| 2023-03-31 | $136 |
| 2022-12-31 | $138 |
| 2022-09-30 | $156 |
| 2022-06-30 | $66 |
| 2022-03-31 | $75 |
| 2021-12-31 | $99 |
| 2021-09-30 | $255 |
| 2021-06-30 | $226 |
| 2021-03-31 | $226 |
| 2020-12-31 | $38 |
| 2020-09-30 | $226 |
| 2020-06-30 | $226 |
| 2020-03-31 | $227 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.324B | $0.393B |
| The Oncology Institute is involved in providing value-based oncology care. The Oncology Institute, formerly known as DFP Healthcare Acquisitions Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.791B | 27.22 |
| CVS Health (CVS) | United States | $91.231B | 11.35 |
| Elevance Health (ELV) | United States | $69.762B | 9.38 |
| Cencora (COR) | United States | $56.333B | 18.76 |
| DiDi Global (DIDIY) | China | $26.403B | 28.05 |
| Labcorp Holdings (LH) | United States | $23.210B | 18.45 |
| Natera (NTRA) | United States | $22.377B | 0.00 |
| BioMerieux (BMXMF) | France | $17.423B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.898B | 0.00 |
| ICON (ICLR) | Ireland | $14.052B | 13.52 |
| Medpace Holdings (MEDP) | United States | $13.301B | 35.20 |
| CochLear (CHEOY) | Australia | $12.977B | 0.00 |
| Solventum (SOLV) | United States | $12.638B | 13.04 |
| Viatris (VTRS) | United States | $12.148B | 4.32 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.748B | 0.00 |
| Revvity (RVTY) | United States | $10.283B | 18.12 |
| Avantor (AVTR) | United States | $8.992B | 13.19 |
| Charles River Laboratories (CRL) | United States | $8.012B | 15.20 |
| Sonic Healthcare (SKHHY) | Australia | $7.799B | 0.00 |
| HealthEquity (HQY) | United States | $7.608B | 33.33 |
| Bausch + Lomb (BLCO) | Canada | $5.151B | 34.64 |
| Sotera Health (SHC) | United States | $4.687B | 26.19 |
| BrightSpring Health Services (BTSG) | United States | $4.239B | 32.34 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.711B | 84.99 |
| Alignment Healthcare (ALHC) | United States | $3.196B | 0.00 |
| Concentras Parent (CON) | United States | $2.993B | 18.98 |
| Surgery Partners (SGRY) | United States | $2.926B | 36.81 |
| Organon (OGN) | United States | $2.392B | 2.61 |
| KindlyMD (NAKA) | United States | $2.377B | 0.00 |
| Premier (PINC) | United States | $2.161B | 20.04 |
| Progyny (PGNY) | United States | $1.979B | 41.85 |
| Ardent Health (ARDT) | United States | $1.819B | 7.02 |
| PACS (PACS) | United States | $1.807B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.564B | 26.47 |
| Pediatrix Medical (MD) | United States | $1.496B | 9.99 |
| Teladoc Health (TDOC) | United States | $1.368B | 0.00 |
| Omada Health (OMDA) | $1.343B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.230B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.853B | 5.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.771B | 9.53 |
| CareDx (CDNA) | United States | $0.707B | 13.03 |
| Performant Healthcare (PHLT) | United States | $0.599B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 100.00 |
| Agilon Health (AGL) | United States | $0.539B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.535B | 0.00 |
| Nutex Health (NUTX) | United States | $0.499B | 7.55 |
| Sonida Senior Living (SNDA) | United States | $0.493B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 6.99 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.453B | 0.00 |
| SBC Medicals (SBC) | United States | $0.434B | 9.50 |
| Enhabit (EHAB) | United States | $0.406B | 26.67 |
| So-Young (SY) | China | $0.399B | 0.00 |
| LifeMD (LFMD) | United States | $0.304B | 0.00 |
| Beauty Health (SKIN) | United States | $0.260B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.240B | 0.00 |
| DocGo (DCGO) | United States | $0.158B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.158B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.107B | 0.00 |
| Biodesix (BDSX) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.036B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| ModivCare (MODV) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |